DETERMINANTS IN PLATELET MICROBICIDAL PROTEINS
血小板杀菌蛋白的决定因素
基本信息
- 批准号:6751207
- 负责人:
- 金额:$ 33.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-07-01 至 2007-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Adapted from the Applicant's Abstract): Human and rabbit
platelets contain platelet microbicidal proteins (PMPs). The investigators'
data show that PMPs play key roles in platelet antimicrobial functions. PMPs
exert potent microbicidal actions against antibiotic-resistant bloodstream
pathogens, including Staphylococcus aureus and Candida albicans. Specific PMPs
are released from platelets exposed to pathogens or agonists at sites of
endovascular infection, and intensify locally at these sites. PMP-susceptible
pathogens are less virulent in animal models than their isogenic PMP-resistant
counterparts. These compelling facts support their hypothesis that PMPs
significantly contribute to antimicrobial host defense. PMPs are minimally
toxic to human vascular endothelial cells or erythrocytes, and differ markedly
in structure and mechanism from antimicrobial peptides that are not released
into the bloodstream. These facts suggest PMPs have key functional determinants
that optimize microbicidal activity without concomitant host cytotoxicity.
Beyond its microbicidal effects, they have discovered that PMP-2 also
potentiates neutrophil chemotaxis, phagocytosis and intracellular killing of S.
aureus. PMP-2 has a cystine-X-cystine (CXC) motif distinctive of
alpha-chemokines such as human platelet factor-4 (hPF-4) that amplify
antimicrobial mechanisms of neutrophils. These facts indicate that PMP-2 is a
unique molecule that exerts both direct microbicidal and
neutrophil-potentiating effects. The investigators' central hypothesis contends
that PMP-2 has specific determinants responsible for these distinct host
defense functions. They further hypothesize these determinants can be defined,
modeled, and used to establish key structure-activity relationships (SARs)
governing specific functions. The proposed studies are designed to explore
these hypotheses. Defining SARs in PMP-2 functional determinants is crucial to
their eventual goal of designing anti-infective agents with potent and/or
selective activity against antibiotic-resistant pathogens. Therefore, their
Specific Aims are: i) to define the structural determinants responsible for
direct microbicidal functions of PMP-2; ii) define the PMP-2 structural
determinants that potentiate the antimicrobial functions of neutrophils; and
iii) establish the key SARs in antimicrobial determinants of PMP-2. Comparison
of PMP-2 and hPF-4 determinants responsible for their potent and/or
discriminative antimicrobial functions will enable future studies of human PMPs
in the rabbit model that cannot be conducted in humans. Moreover, SAR themes
discovered in PMP-2 will accelerate discovery of novel anti-infective
strategies against pathogens resistant to conventional agents. Thus, these
studies will significantly advance our understanding of antimicrobial host
defense, and may yield new modes for its amplification.
描述(改编自申请人的摘要):人类和兔子
血小板含有血小板杀菌蛋白(PMP)。调查人员的
数据表明,PMP在血小板抗菌功能中起关键作用。 PMP
针对抗生素耐药性血液施加有效的杀生性作用
病原体,包括金黄色葡萄球菌和白色念珠菌。特定的PMP
从暴露于病原体或激动剂处的血小板中释放
血管内感染,并在这些部位局部增强。 PMP敏感
病原体在动物模型中的毒性要比其抗性PMP耐药性少。
同行。这些令人信服的事实支持了他们的假设
显着有助于抗菌宿主防御。 PMP最少
对人血管内皮细胞或红细胞有毒,并明显不同
在未释放的抗菌肽的结构和机制中
进入血液。这些事实表明PMP具有关键功能决定因素
这可以优化无伴随宿主细胞毒性的微生物活性。
除了其杀菌作用之外,他们还发现PMP-2也
增强中性粒细胞趋化性,吞噬作用和细胞内杀害。
金黄色葡萄酒。 PMP-2具有与众不同的Cystine-X-Cystine(CXC)图案
α-α-变化代因,例如人血小板因子-4(HPF-4),它放大
中性粒细胞的抗菌机制。这些事实表明PMP-2是
施用直接杀生和施用的独特分子
中性粒细胞抑制作用。研究者的中央假设争辩
PMP-2具有负责这些不同主机的特定决定因素
国防功能。他们进一步假设可以定义这些决定因素,
建模并用于建立关键的结构活性关系(SARS)
管理特定功能。拟议的研究旨在探索
这些假设。在PMP-2功能决定因素中定义SARS对
他们最终的目标是设计具有强大和/或的反感染剂
针对抗生素耐药病原体的选择性活性。因此,他们
具体目的是:i)定义负责的结构决定因素
PMP-2的直接杀生功能; ii)定义PMP-2结构
增强中性粒细胞抗菌功能的决定因素;和
iii)在PMP-2的抗菌决定因素中建立关键SAR。比较
负责其有效和/或负责的PMP-2和HPF-4决定因素
歧视性抗菌功能将使未来的人类PMP研究
在人类无法进行的兔模型中。此外,SAR主题
在PMP-2中发现将加速发现新型抗感染性
抗病原体对常规药物的策略。因此,这些
研究将大大提高我们对抗菌宿主的理解
防御,并可能产生新模式以进行放大。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Efficacy of synthetic peptides RP-1 and AA-RP-1 against Leishmania species in vitro and in vivo.
合成肽 RP-1 和 AA-RP-1 对利什曼原虫的体外和体内功效。
- DOI:10.1128/aac.05349-11
- 发表时间:2012
- 期刊:
- 影响因子:4.9
- 作者:Erfe,MarieCriselB;David,ConsueloV;Huang,Cher;Lu,Victoria;Maretti-Mira,AnaClaudia;Haskell,Jacquelyn;Bruhn,KevinW;Yeaman,MichaelR;Craft,Noah
- 通讯作者:Craft,Noah
Emerging themes and therapeutic prospects for anti-infective peptides.
- DOI:10.1146/annurev-pharmtox-010611-134535
- 发表时间:2012-01
- 期刊:
- 影响因子:12.5
- 作者:N. Yount;M. Yeaman
- 通讯作者:N. Yount;M. Yeaman
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael R Yeaman其他文献
Michael R Yeaman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael R Yeaman', 18)}}的其他基金
Systems Epigenomics of Persistent Bloodstream Infection
持续性血流感染的系统表观基因组学
- 批准号:
10551703 - 财政年份:2023
- 资助金额:
$ 33.95万 - 项目类别:
Epigenomic Mechanisms & Contextual Immunity in Persistent MRSA Bacteremia
表观基因组机制
- 批准号:
10551708 - 财政年份:2023
- 资助金额:
$ 33.95万 - 项目类别:
Systems Immunolobiology of Antibiotic-Persistent MRSA Infection
抗生素持续性 MRSA 感染的系统免疫学
- 批准号:
9246423 - 财政年份:2016
- 资助金额:
$ 33.95万 - 项目类别:
Systems Immunolobiology of Antibiotic-Persistent MRSA Infection
抗生素持续性 MRSA 感染的系统免疫学
- 批准号:
9108773 - 财政年份:2016
- 资助金额:
$ 33.95万 - 项目类别:
Novel Context-Activated Protide Anti-Infectives
新型环境激活蛋白肽抗感染药
- 批准号:
7218790 - 财政年份:2007
- 资助金额:
$ 33.95万 - 项目类别:
Novel Context-Activated Protide Anti-Infectives
新型环境激活蛋白肽抗感染药
- 批准号:
7429814 - 财政年份:2007
- 资助金额:
$ 33.95万 - 项目类别:
相似国自然基金
农用杀菌剂胁迫下根系微生物群落演替及其对植物生长免疫的调控
- 批准号:21976161
- 批准年份:2019
- 资助金额:66 万元
- 项目类别:面上项目
相似海外基金
Snodgrassella alvi as an attenuated live vaccine against Neisseria gonorrhoeae
Snodgrassella alvi 作为针对淋病奈瑟菌的减毒活疫苗
- 批准号:
10263891 - 财政年份:2020
- 资助金额:
$ 33.95万 - 项目类别:
Hyperbaric oxygen mechanisms of protection in sepsis
高压氧对脓毒症的保护机制
- 批准号:
6882668 - 财政年份:2004
- 资助金额:
$ 33.95万 - 项目类别:
Hyperbaric oxygen mechanisms of protection in sepsis
高压氧对脓毒症的保护机制
- 批准号:
6769746 - 财政年份:2004
- 资助金额:
$ 33.95万 - 项目类别: